$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
AbbVie Inc. $ABBV Shares Bought by Sara Bay Financial
05:56am, Monday, 22'nd Dec 2025
Sara Bay Financial grew its stake in AbbVie Inc. (NYSE: ABBV) by 21.2% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The
Foster Victor Wealth Advisors LLC Raises Stock Position in AbbVie Inc. $ABBV
05:56am, Monday, 22'nd Dec 2025
Foster Victor Wealth Advisors LLC increased its position in shares of AbbVie Inc. (NYSE: ABBV) by 4.2% during the third quarter, according to its most recent filing with the Securities and Exchange Co
AbbVie Inc. $ABBV is CHICAGO TRUST Co NA’s 8th Largest Position
05:12am, Monday, 22'nd Dec 2025
CHICAGO TRUST Co NA trimmed its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 10.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchang
Charles Schwab Trust Co Acquires 15,502 Shares of AbbVie Inc. $ABBV
05:12am, Monday, 22'nd Dec 2025
Charles Schwab Trust Co raised its holdings in AbbVie Inc. (NYSE: ABBV) by 93.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
04:44am, Monday, 22'nd Dec 2025
AbbVie is a Dividend King that successfully navigated a challenging patent cliff. Coca-Cola is a household name that has survived and thrived for 139 years.
3 Dividend Growth Stocks Analysts Are Upgrading for 2026
09:23am, Sunday, 21'st Dec 2025
A single analyst's rating and price target, the consensus rating and price target, for that matter, have little value to investors without the proper context. The context is the sentiment strength and
AbbVie Inc. $ABBV Shares Sold by BDF Gestion
03:54am, Sunday, 21'st Dec 2025
BDF Gestion lessened its position in AbbVie Inc. (NYSE: ABBV) by 17.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
01:38am, Saturday, 20'th Dec 2025
Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc
04:01pm, Friday, 19'th Dec 2025
Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2
Trump to announce new drug-pricing deals later today
10:45am, Friday, 19'th Dec 2025
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.
Is AbbVie a Millionaire Maker?
04:30pm, Thursday, 18'th Dec 2025
AbbVie is a pharmaceutical company with a focus on immunology, oncology, neuroscience, and aesthetics. The company's third-quarter earnings were down materially year over year, but it raised its full-
Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.
01:45pm, Thursday, 18'th Dec 2025
Invest in stocks with good fundamentals, solid growth prospects, and steady dividends. These blue chip stocks have strong businesses that generate consistently strong results.
Retirees Banking on Quarterly Income Choose HDV Over Growth Funds for Its Defensive Holdings
09:03am, Thursday, 18'th Dec 2025
When income matters more than growth, retirees turn to funds that deliver quarterly checks without volatility. The iShares Core High Dividend ETF (NYSEARCA:HDV) yields 3.3%, triple the S&P 500's 1.03%
AbbVie Inc. $ABBV Shares Sold by Carolina Wealth Advisors LLC
05:58am, Thursday, 18'th Dec 2025
Carolina Wealth Advisors LLC lessened its stake in shares of AbbVie Inc. (NYSE: ABBV) by 98.4% during the third quarter, according to the company in its most recent disclosure with the Securities and
Grant Private Wealth Management Inc Sells 8,979 Shares of AbbVie Inc. $ABBV
04:56am, Thursday, 18'th Dec 2025
Grant Private Wealth Management Inc cut its position in AbbVie Inc. (NYSE: ABBV) by 75.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC
Sign In
Buy ABBV